Cargando…
Impact of CD14(++)CD16(+) monocytes on plaque vulnerability in diabetic and non-diabetic patients with asymptomatic coronary artery disease: a cross-sectional study
BACKGROUND: Previously, we have reported that daily glucose fluctuations could affect coronary plaque vulnerability, but the underlying mechanisms remained unclear. This study sought to investigate the impact of CD14(++)CD16(+) monocytes on plaque vulnerability, as assessed by virtual histology intr...
Autores principales: | Yoshida, Naofumi, Yamamoto, Hiroyuki, Shinke, Toshiro, Otake, Hiromasa, Kuroda, Masaru, Terashita, Daisuke, Takahashi, Hachidai, Sakaguchi, Kazuhiko, Hirota, Yushi, Emoto, Takuo, Amin, Hilman Zulkifli, Mizoguchi, Taiji, Hayashi, Tomohiro, Sasaki, Naoto, Yamashita, Tomoya, Ogawa, Wataru, Hirata, Ken-ichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549371/ https://www.ncbi.nlm.nih.gov/pubmed/28789689 http://dx.doi.org/10.1186/s12933-017-0577-8 |
Ejemplares similares
-
Association between daily glucose fluctuation and coronary plaque properties in patients receiving adequate lipid-lowering therapy assessed by continuous glucose monitoring and optical coherence tomography
por: Kuroda, Masaru, et al.
Publicado: (2015) -
Data on impact of monocytes and glucose fluctuation on plaque vulnerability in patients with coronary artery disease
por: Yamamoto, Hiroyuki, et al.
Publicado: (2018) -
Effects of daily glucose fluctuations on the healing response to everolimus-eluting stent implantation as assessed using continuous glucose monitoring and optical coherence tomography
por: Kuroda, Masaru, et al.
Publicado: (2016) -
Ultraviolet B Exposure Inhibits Angiotensin II–Induced Abdominal Aortic Aneurysm Formation in Mice by Expanding CD4(+)Foxp3(+) Regulatory T Cells
por: Hayashi, Tomohiro, et al.
Publicado: (2017) -
Impact of daily glucose fluctuations on cardiovascular outcomes after percutaneous coronary intervention for patients with stable coronary artery disease undergoing lipid‐lowering therapy
por: Yamamoto, Hiroyuki, et al.
Publicado: (2020)